Epithelial-mesenchymal transition and resistance to EGFR inhibitors
- 8 February 2023
- book chapter
- Published by Elsevier
- p. 105-124
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancerNature Genetics, 2012
- Transcriptional Activation of ZEB1 by Slug Leads to Cooperative Regulation of the Epithelial–Mesenchymal Transition-Like Phenotype in MelanomaJournal of Investigative Dermatology, 2011
- Epithelial to Mesenchymal Transition in an Epidermal Growth Factor Receptor-Mutant Lung Cancer Cell Line with Acquired Resistance to ErlotinibJournal of Thoracic Oncology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- A systems view of epithelial–mesenchymal transition signaling statesClinical & Experimental Metastasis, 2010
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOncogene, 2010
- Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibitionProceedings of the National Academy of Sciences, 2009
- Snail and Slug Promote Epithelial-Mesenchymal Transition through β-Catenin–T-Cell Factor-4-dependent Expression of Transforming Growth Factor-β3Molecular Biology of the Cell, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006